← back to search

Colleen Sweeney

UC Davis Health · US
Area of research
Molecular Biology · Oncology
Research interest
Research interests include RNA modifications and cancer, Glycosylation and Glycoproteins Research, HER2/EGFR in Cancer Research, and Ubiquitin and proteasome pathways.
h-index
46
citations
5,995
works
180
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Aberrant promoter methylation contributes to LRIG1 silencing in basal/triple-negative breast cancer.
2022cited by 18position: contributordoi
Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells
Nature Communications 2020cited by 145position: middledoi
Targeting the polyamine pathway—“a means” to overcome chemoresistance in triple-negative breast cancer
Journal of Biological Chemistry 2020cited by 7position: contributordoi
The Transcription Factor ZNF217 Is a Prognostic Biomarker and Therapeutic Target during Breast Cancer Progression
Cancer Discovery 2012cited by 90position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

— · 2 papers (2020–2022)Gerrit J.P. Dijkgraaf · Molecular Oncology (United States)1 papers (2012–2012)Hosein Kouros‐Mehr · College of San Mateo1 papers (2012–2012)Adam S. Adler · GigaGen (United States)1 papers (2012–2012)Mark D. Sternlicht · FibroGen (United States)1 papers (2012–2012)Jonathan Chou · UCSF Helen Diller Family Comprehensive Cancer Center1 papers (2012–2012)Joe W. Gray · Directorate-General for Interpretation1 papers (2012–2012)Devon A. Lawson · University of California, Irvine1 papers (2012–2012)James E. Korkola · Oregon Health & Science University1 papers (2012–2012)Howard Y. Chang · Amgen (United States)1 papers (2012–2012)Kun Qu · PAX Scientific (United States)1 papers (2012–2012)Zena Werb · University of California, San Francisco1 papers (2012–2012)Colin C. Collins · University of British Columbia1 papers (2012–2012)Paul Yaswen · University of Nevada, Reno1 papers (2012–2012)Laurie E. Littlepage · University of Notre Dame1 papers (2012–2012)Sheryl R. Krig · California Northstate University1 papers (2012–2012)Hope S. Rugo · UCSF Helen Diller Family Comprehensive Cancer Center1 papers (2012–2012)Qing Xue · Capital Medical University1 papers (2012–2012)Guiqing Huang · Sanya University1 papers (2012–2012)David J. Segal · UC Davis Health System1 papers (2022–2022)